With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market. By Christina Jewett The Food and Drug Administration is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback